Brighton Jones’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
Brighton Jones's MXCT Position: Q3 2026 in Review
Brighton Jones sold out of MaxCyte (MXCT) in Q3 2026, closing a stake of 24,157 shares — an estimated $29.7K sold.
Brighton Jones first reported a position in MXCT in Q1 2026 and held it in 2 quarters. The position peaked at $29.7K in Q2 2026. 97 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.
- Brighton Jones reported no remaining MaxCyte position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 24,157 MaxCyte shares in Q3 2026, an estimated $29.7K.
- Brighton Jones first reported a position in MaxCyte in Q1 2026 and held it in 2 quarters.
- Brighton Jones's MaxCyte position peaked at $29.7K in Q2 2026.
- 97 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.